8 hours SNY Inks Deal With Orano Med for Next-Generation Radioligand TherapiesZacks
Sanofi inks an agreement with Orano Med to develop next-generation radioligand medicines to treat rare cancers.
XSanofi inks an agreement with Orano Med to develop next-generation radioligand medicines to treat rare cancers.
X